Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0000950170-24-118343
Filing Date
2024-10-29
Accepted
2024-10-29 17:05:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B/A kzr-8-aa_-_rights.htm 8-A12B/A 33885
  Complete submission text file 0000950170-24-118343.txt   34926
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B/A | Act: 34 | File No.: 001-38542 | Film No.: 241406572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)